Delivery Order SPE2DB22D3301-SPE2DB25FY3RW

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,215.64 firm fixed-price delivery order contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,826.24, is for the delivery of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat and prevent certain types of ulcers. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $12,277.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, a medication used to treat various gastrointestinal conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $31,577.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,217,345 units of Sucralfate 1 GM Tablet 90S, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a...
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB24FV8PZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,765.73, is a delivery order for the supply of sucralfate 1 gram tablets. It is a firm fixed-price contract with a completion date of March 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ52T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,688.20 firm fixed-price delivery order is for the supply of 4,563,214,896 units of Sucralfate 1 GM/10 ML Suspension, with a completion date of January 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,514,018 sucralfate 1 gram tablets. The contract has a ceiling value of $8,282.75 and a period of performance ending on May 7, 2024. The contract is a firm-fixed-price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAMW8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,909.12 firm fixed-price delivery order is for the supply of 420 mL bottles of 1 gram/10 mL Sucralfate suspension. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.59, is for the delivery of sucralfate 1 gram tablets in quantities of 90 per bottle. The contract has an ultimate completion date of November 30, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat digestive issues, with a ceiling value of $10,616.12. The contract has a firm fixed price pricing type and a period of performance through May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) the...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY3RW
    Delivery Order

This federal contract award, SPE2DB22D3301|SPE2DB25FY3RW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,782.12 firm fixed-price delivery order is for the supply of 4,568,000 Sucralfate 1 GM Tablet 90S, a medication used to treat peptic ulcers. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/22/25, 10:11 AM